Hospital Mater Dei S.A. (BVMF:MATD3)
Brazil · Delayed Price · Currency is BRL | Market Cap | 1.66B +5.1% |
| Revenue (ttm) | 2.25B +5.1% |
| Net Income | 123.79M |
| EPS | 0.37 |
| Shares Out | 331.89M |
| PE Ratio | 13.53 |
| Forward PE | 9.08 |
| Dividend | 0.15 (3.00%) |
| Ex-Dividend Date | Dec 9, 2025 |
| Volume | 292,100 |
| Open | 5.03 |
| Previous Close | 4.94 |
| Day's Range | 5.01 - 5.11 |
| 52-Week Range | 4.13 - 6.17 |
| Beta | 0.44 |
| Analysts | Buy |
| Price Target | 7.10 (+41.72%) |
| Earnings Date | Aug 10, 2026 |
About Hospital Mater Dei
Hospital Mater Dei S.A. operates hospitals in Brazil. It engages in data and artificial intelligence business. The company was incorporated in 1973 and is headquartered in Belo Horizonte, Brazil. Hospital Mater Dei S.A. is a subsidiary of JSS Empreendimentos e Administração LTDA. [Read more]
Financial Performance
Financial StatementsNews
Hospital Mater Dei Earnings Call Transcript: Q1 2026
Record Q1 2026 results with net revenue up 15% and EBITDA up 35% year-over-year, driven by higher average ticket, operational efficiency, and strong performance in oncology. Leverage improved, margins expanded, and disciplined capital allocation remains a priority.
Hospital Mater Dei Earnings release: Q1 2026
Hospital Mater Dei released its Q1 2026 earnings on May 6, 2026, summarizing the period's financial results.
Hospital Mater Dei Slides: Q1 2026
Hospital Mater Dei has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 6, 2026.
Hospital Mater Dei Earnings release: Q4 2025
Hospital Mater Dei released its Q4 2025 earnings on March 22, 2026, summarizing the period's financial results.
Hospital Mater Dei Slides: Q4 2025
Hospital Mater Dei has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 22, 2026.
Hospital Mater Dei Earnings Call Transcript: Q3 2025
Record Q3 2025 results with net revenue of BRL 570 million and EBITDA up 39% year-over-year, driven by higher average ticket, operational efficiency, and strong performance in oncology and key units. Leverage reduced to 1.8x, with robust cash generation and continued focus on margin expansion.
Hospital Mater Dei Earnings release: Q3 2025
Hospital Mater Dei released its Q3 2025 earnings on November 10, 2025, summarizing the period's financial results.
Hospital Mater Dei Slides: Q3 2025
Hospital Mater Dei has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on November 10, 2025.
Hospital Mater Dei Earnings Call Transcript: Q2 2025
Record Q2 2025 revenue and EBITDA were achieved through higher complexity procedures, operational efficiency, and disciplined cost control. Key units like Salvador and Nova Lima delivered strong growth, while leverage and cash flow improved, supporting further debt prepayment and expansion plans.
Hospital Mater Dei Earnings release: Q2 2025
Hospital Mater Dei released its Q2 2025 earnings on August 14, 2025, summarizing the period's financial results.
Hospital Mater Dei Slides: Q2 2025
Hospital Mater Dei has posted slides in relation to its Q2 2025 quarterly earnings report, which was published on August 14, 2025.